Bliss GVS Pharma’s Stock Sees 7.69% Increase, Outperforms Pharmaceutical Industry
On October 28, 2024, Bliss GVS Pharma’s stock price increased by 7.69%, in line with the pharmaceutical and drugs industry.
Read MoreOn October 28, 2024, Bliss GVS Pharma’s stock price increased by 7.69%, in line with the pharmaceutical and drugs industry.
Read MoreSeniors, be prepared: If Tom Kean Jr. is re-elected and gets his way, you’ll have to pay a lot more
Read More– Advertisement – As the global focus shifts toward environmental responsibility, the pharmaceutical industry is increasingly recognizing the importance of
Read MoreData from a wide range of the Sun Pharma dermatology portfolio, including data on alopecia areata, psoriasis, acne and actinic
Read MoreKey Highlights: Global Heat Transfer, has launched a new cleaning and flushing fluid — Globaltherm C1 HF. Globaltherm C1 HF helps to
Read MoreCAIRO – 22 October 2024: On the sidelines of the 81st session of the African Commission on Human and Peoples’
Read MoreThe demand for reliable transportation solutions in the pharmaceutical industry in Austria and in the surrounding Eastern European countries has
Read MoreBy Nora CaleyFrom the September/October 2024 Issue (Photo: Adobe Stock / Sergey Nivens) From blockbuster drugs that garner media attention to
Read MoreDuring the reporting period, Imexpharm continued to capitalise on its leadership position in the industry. The company also successfully completed
Read MoreDeals: Lundbeck is buying Longboard Pharmaceuticals for $2.6 billion. Cycle Pharmaceuticals reaffirmed its offer to buy Vanda Pharmaceuticals in a
Read More